Pacific Biosciences(DE:P09)
€1.65-0.03 (-1.73%)
DE:P09
Pacific Biosciences ownership
€1.65
At close:-0.03 (-1.73%)
Pacific Biosciences (P09) Ownership - Who Owns Pacific Biosciences?
6 Followers
Pacific Biosciences (P09) Ownership Overview
- 2.75% Insiders
- 9.59% Mutual Funds
- 33.74% Other Institutional Investors
- 24.33% ETFs
- 29.59% Public Companies and Individual Investors
The ownership structure of Pacific Biosciences (DE:P09) stock is a mix of institutional, retail, and individual investors. Approximately 67.66% of the company’s stock is owned by Institutional Investors, 2.75% is owned by Insiders, and 29.59% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Pacific Biosciences (DE:P09) stock is a mix of institutional, retail, and individual investors. Approximately 67.66% of the company’s stock is owned by Institutional Investors, 2.75% is owned by Insiders, and 29.59% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 17, 2026 | Mark Van Oene | $30,409 | |
| Apr 02, 2026 | James R. Gibson | $120,813 | |
| Mar 03, 2026 | Christian Henry | $18,870 | |
| Mar 03, 2026 | Michele Farmer | $4,498 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €352,466 | |
| Dec 31, 2025 | Ark Investment Management Llc | €69,684,106 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ark | 42,206,638 | Institution | 13.49% | 76,394,015 |
| BlackRock, Inc. | 32,802,532 | Institution | 10.48% | 59,372,583 |
| Cathie Wood | 29,749,893 | Institution | 9.51% | 53,847,306 |
| Ishares | 15,044,453 | Institution | 4.81% | 27,230,460 |
| Vanguard | 13,973,909 | Institution | 4.47% | 25,292,775 |
| Vanguard Index Funds | 13,116,585 | Institution | 4.19% | 23,741,019 |
| Christian Henry | 3,581,813 | Insider | 1.14% | 6,483,082 |
| Fidelity Salem Street Trust | 3,376,532 | Institution | 1.08% | 6,111,523 |
| Fidelity Concord Street Trust | 2,971,315 | Institution | 0.95% | 5,378,080 |
| Blackrock Funds | 2,967,098 | Institution | 0.95% | 5,370,447 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 13,116,585 | Institution | 4.19% | 23,741,019 |
| Fidelity Salem Street Trust | 3,376,532 | Institution | 1.08% | 6,111,523 |
| Fidelity Concord Street Trust | 2,971,315 | Institution | 0.95% | 5,378,080 |
| Blackrock Funds | 2,967,098 | Institution | 0.95% | 5,370,447 |
| Vanguard Scottsdale Funds | 1,945,143 | Institution | 0.62% | 3,520,709 |
| Tiaa-cref Funds | 1,512,451 | Institution | 0.48% | 2,737,536 |
| Schwab Capital Trust | 974,945 | Institution | 0.31% | 1,764,650 |
| Vanguard World Fund | 735,896 | Institution | 0.24% | 1,331,972 |
| Northern Funds | 331,718 | Institution | 0.11% | 600,410 |
| American Beacon Funds | 319,798 | Institution | 0.10% | 578,834 |
FAQ
Who Owns Pacific Biosciences (DE:P09)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 67.66% of the company's stock is held by institutional investors, 2.75% is held by insiders, and 29.59% is held by public companies and individual investors.
What percentage of Pacific Biosciences (DE:P09) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 67.66% of Pacific Biosciences (DE:P09) stock is held by institutional investors: 9.59% by mutual funds, 24.33% by ETFs and 33.74% by other institutional investors.
What percentage of Pacific Biosciences (DE:P09) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 29.59% of Pacific Biosciences (DE:P09) stock is held by public companies and individual investors.
Who owns the most shares of Pacific Biosciences (DE:P09)?
ARK owns the most shares of Pacific Biosciences (DE:P09).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

